ATLAS / Macro Radar / Reporting / CRVS

Corvus Pharmaceuticals, Inc. (CRVS) reporting calendar

Corvus Pharmaceuticals, Inc. files periodic reports with the SEC as CRVS on Nasdaq. Atlas tracks 41 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
14 Jul 2026 – 31 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
41

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CRVS market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001104659-26-057100
10-K31 Dec 202512 Mar 202671 days0001104659-26-027047
10-Q30 Sep 20254 Nov 202535 days0001104659-25-106259
10-Q30 Jun 20257 Aug 202538 days0001558370-25-010755
10-Q31 Mar 20258 May 202538 days0001558370-25-006966
10-K31 Dec 202425 Mar 202584 days0001558370-25-003621
10-Q30 Sep 202412 Nov 202443 days0001558370-24-015306
10-Q30 Jun 20246 Aug 202437 days0001558370-24-011076
10-Q31 Mar 20247 May 202437 days0001558370-24-007093
10-K31 Dec 202319 Mar 202479 days0001558370-24-003567
10-Q30 Sep 20237 Nov 202338 days0001558370-23-017981
10-Q30 Jun 20238 Aug 202339 days0001558370-23-013914
10-Q31 Mar 20238 May 202338 days0001558370-23-008503
10-K31 Dec 202228 Mar 202387 days0001558370-23-004792
10-Q30 Sep 20223 Nov 202234 days0001558370-22-016233
10-Q30 Jun 20228 Aug 202239 days0001558370-22-012619
10-Q31 Mar 20225 May 202235 days0001558370-22-007374
10-K31 Dec 202110 Mar 202269 days0001558370-22-003281
10-Q30 Sep 20211 Nov 202132 days0001558370-21-013913
10-Q30 Jun 20212 Aug 202133 days0001558370-21-009818
10-Q31 Mar 202129 Apr 202129 days0001558370-21-005258
10-K31 Dec 202025 Mar 202184 days0001558370-21-003462
10-Q30 Sep 202029 Oct 202029 days0001558370-20-012039
10-Q30 Jun 202030 Jul 202030 days0001558370-20-008756
10-Q31 Mar 202030 Apr 202030 days0001558370-20-004797
10-K31 Dec 20199 Mar 202069 days0001558370-20-002232
10-Q30 Sep 201929 Oct 201929 days0001558370-19-009354
10-Q30 Jun 20191 Aug 201932 days0001558370-19-006824
10-Q31 Mar 20199 May 201939 days0001558370-19-004697
10-K31 Dec 20187 Mar 201966 days0001558370-19-001660
10-Q30 Sep 20181 Nov 201832 days0001558370-18-008268
10-Q30 Jun 20182 Aug 201833 days0001558370-18-006236
10-Q31 Mar 20183 May 201833 days0001104659-18-030262
10-K31 Dec 20171 Mar 201860 days0001047469-18-001209
10-Q30 Sep 20172 Nov 201733 days0001104659-17-065655
10-Q30 Jun 20173 Aug 201734 days0001104659-17-049313
10-Q31 Mar 20174 May 201734 days0001104659-17-029890
10-K31 Dec 201610 Mar 201769 days0001047469-17-001459
10-Q30 Sep 20163 Nov 201634 days0001104659-16-154578
10-Q30 Jun 20164 Aug 201635 days0001104659-16-137057

Source: SEC EDGAR company submissions for CIK 0001626971. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.